{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:48:27Z","timestamp":1757310507043},"reference-count":32,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bulcan.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T17:02:56Z","timestamp":1431104576000},"page":"648-655","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["S\u00e9quelles post-allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques"],"prefix":"10.1016","volume":"102","author":[{"given":"Eva","family":"de Berranger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Jubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bulcan.2015.04.005_bib0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.patbio.2014.05.009","article-title":"Managing late-effects after allogeneic stem cell transplantation in children\u00a0: recommendations from the SFGM-TC","volume":"62","author":"de Berranger","year":"2014","journal-title":"Pathol Biol"},{"issue":"7","key":"10.1016\/j.bulcan.2015.04.005_bib0010","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbmt.2013.04.015","article-title":"A French cohort of childhood leukemia survivors: impact of hematopoietic stem cell transplantation on health status and quality of life","volume":"19","author":"Berbis","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bulcan.2015.04.005_bib0015","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1705821","article-title":"Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation","volume":"40","author":"Michel","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bulcan.2015.04.005_bib0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1182\/blood-2011-01-332866","article-title":"Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities","volume":"118","author":"Le Meignen","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bulcan.2015.04.005_bib0025","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3324\/haematol.2012.081265","article-title":"Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood","volume":"98","author":"Girard","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bulcan.2015.04.005_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.patbio.2013.07.009","article-title":"Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on adrenal insufficiency and osteoporosis","volume":"61","author":"Cornillon","year":"2013","journal-title":"Pathol Biol"},{"issue":"22","key":"10.1016\/j.bulcan.2015.04.005_bib0035","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.2011.34.6585","article-title":"Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"29","author":"Armstrong","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2015.04.005_bib0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MPH.0b013e31828e5d96","article-title":"Nonmelanoma skin cancer in childhood after hematopoietic stem cell transplant: a report of 4\u00a0cases","volume":"36","author":"Rork","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bulcan.2015.04.005_bib0045","series-title":"Brochure de questions\/r\u00e9ponses destin\u00e9e aux professionnels de sant\u00e9. Vfend\u00ae (voriconazole) par voie orale\/intraveineuse","first-page":"6","author":"Pfizer","year":"2014"},{"issue":"9","key":"10.1016\/j.bulcan.2015.04.005_bib0050","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","article-title":"Ocular findings after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Tabbara","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.bulcan.2015.04.005_bib0055","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/bjh.13148","article-title":"Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: a LEA study","volume":"168","author":"Horwitz","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bulcan.2015.04.005_bib0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.seminhematol.2011.10.012","article-title":"Long-term follow-up and management guidelines in pediatric patients after allogenic hematopoietic stem cell transplantation","volume":"49","author":"Frangoul","year":"2012","journal-title":"Semin Hematol"},{"issue":"8","key":"10.1016\/j.bulcan.2015.04.005_bib0065","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/bmt.2008.370","article-title":"Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI","volume":"43","author":"Bernard","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bulcan.2015.04.005_bib0070","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bmt.2011.139","article-title":"Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or\/and cranial irradiation in childhood: a report from the French leukaemia long-term follow-up study (LEA)","volume":"47","author":"Isfan","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2015.04.005_bib0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.patbio.2013.07.008","article-title":"Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on gonadal failure and fertility","volume":"61","author":"Cornillon","year":"2013","journal-title":"Pathol Biol"},{"issue":"1","key":"10.1016\/j.bulcan.2015.04.005_bib0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.fertnstert.2011.03.108","article-title":"Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence","volume":"96","author":"Jadoul","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bulcan.2015.04.005_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/bmt.2011.78","article-title":"Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence","volume":"47","author":"Borgmann-Staudt","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bulcan.2015.04.005_bib0090","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bbmt.2011.10.006","article-title":"NCI, NHLBI\/PBMTC first international conference on late-effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks","volume":"17","author":"Dvorak","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2015.04.005_bib0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-014-0162-0","article-title":"Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation","volume":"9","author":"Vantyghem","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.bulcan.2015.04.005_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5144\/1658-3876.2012.1","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"5","author":"Majhail","year":"2012","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"4","key":"10.1016\/j.bulcan.2015.04.005_bib0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.patbio.2013.07.010","article-title":"Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders","volume":"61","author":"Cornillon","year":"2013","journal-title":"Pathol Biol"},{"issue":"3","key":"10.1016\/j.bulcan.2015.04.005_bib0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-126-3-199702010-00002","article-title":"Health and functional status of long-term survivors of bone marrow transplantation. EBMT working party on late-effects and EULEP Study Group on late-effects. European Group for Blood and Marrow Transplantation","volume":"126","author":"Duell","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.bulcan.2015.04.005_bib0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.arcped.2005.10.008","article-title":"Walking tests: a step forward for functional cardiorespiratory assessment","volume":"13","author":"Pouessel","year":"2006","journal-title":"Arch Pediatr"},{"issue":"3","key":"10.1016\/j.bulcan.2015.04.005_bib0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bmt.1705710","article-title":"Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies","volume":"40","author":"Ferry","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2015.04.005_bib0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/bmt.2012.179","article-title":"Risk factors affecting cardiac left-ventricular hypertrophy and systolic and diastolic function in the chronic phase of allogeneic hematopoietic cell transplantation","volume":"48","author":"Nishimoto","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2015.04.005_bib0130","series-title":"Long-term follow-up after hematopoietic stem cell transplant general guidelines","first-page":"101","author":"Fred Hutchinson Cancer Research Center\/Seattle Cancer Care Alliance","year":"2014"},{"issue":"6","key":"10.1016\/j.bulcan.2015.04.005_bib0135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3324\/haematol.11063","article-title":"Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT)","volume":"92","author":"Rose","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bulcan.2015.04.005_bib0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.crd.0000380842.14048.7e","article-title":"Diagnosis and management of the metabolic syndrome. An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary","volume":"13","author":"Grundy","year":"2005","journal-title":"Cardiol Rev"},{"issue":"17","key":"10.1016\/j.bulcan.2015.04.005_bib0145","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1182\/blood-2010-09-304899","article-title":"Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia","volume":"117","author":"Oudin","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bulcan.2015.04.005_bib0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbmt.2009.11.018","article-title":"Hypertension in long-term survivors of pediatric hematopoietic cell transplantation","volume":"16","author":"Hoffmeister","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2015.04.005_bib0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.nephro.2014.03.002","article-title":"Renal complications after hematopoietic stem cell transplantation","volume":"10","author":"Abboud","year":"2014","journal-title":"Nephrol Ther"},{"issue":"1","key":"10.1016\/j.bulcan.2015.04.005_bib0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.seminhematol.2011.10.008","article-title":"Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: monitoring and management guidelines","volume":"49","author":"Abboud","year":"2012","journal-title":"Semin Hematol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115001447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115001447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T15:31:45Z","timestamp":1651937505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115001447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":32,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0007455115001447"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.04.005","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00e9quelles post-allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}